SpringWorks Therapeutics Inc (SWTX)
45.21
+1.01
(+2.29%)
USD |
NASDAQ |
Apr 26, 10:08
SpringWorks Therapeutics Cash from Operations (TTM): -222.80M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -222.80M |
| September 30, 2023 | -214.29M |
| June 30, 2023 | -183.43M |
| March 31, 2023 | -174.69M |
| December 31, 2022 | -161.56M |
| September 30, 2022 | -153.68M |
| June 30, 2022 | -161.00M |
| March 31, 2022 | -155.46M |
| December 31, 2021 | -127.88M |
| Date | Value |
|---|---|
| September 30, 2021 | -66.50M |
| June 30, 2021 | -54.27M |
| March 31, 2021 | -36.90M |
| December 31, 2020 | -32.19M |
| September 30, 2020 | -63.32M |
| June 30, 2020 | -59.73M |
| March 31, 2020 | -56.66M |
| December 31, 2019 | -47.44M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-222.80M
Minimum
Dec 2023
-32.19M
Maximum
Dec 2020
-115.99M
Average
-127.88M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| Syndax Pharmaceuticals Inc | -160.60M |
| Alnylam Pharmaceuticals Inc | 104.16M |
| Geron Corp | -167.74M |
| Ionis Pharmaceuticals Inc | -307.51M |
| Madrigal Pharmaceuticals Inc | -324.23M |